Viewing Study NCT06667050


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2025-12-26 @ 11:32 PM
Study NCT ID: NCT06667050
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-31
First Post: 2024-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Sponsor: West China Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
Keywords: